Stay updated on Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe screenshots show only minor layout and formatting adjustments; the core study data (title, NCT03657043, conditions, eligibility criteria, outcomes, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a Publications section citing a new PubMed article (new core content and proper nouns) with a full bibliographic reference; no deletions present.SummaryDifference2%

- Check30 days agoChange Detected- Added a government funding lapse notice and operating status guidance, and a new version tag (v3.2.0). - Removed the previous version tag (v3.1.0).SummaryDifference2%

- Check38 days agoChange DetectedThe page now indicates a new release (v3.1.0) and has removed the Ovarian cancer resource under Genetic and Rare Diseases Information Center, as well as the older revision tag (v3.0.2).SummaryDifference0.3%

- Check52 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.